PlainRecalls
FDA Drug Moderate Class II Terminated

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019

Reported: May 8, 2019 Initiated: April 19, 2019 #D-1271-2019

Product Description

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019

Reason for Recall

Defective Delivery System: difficult to express

Details

Units Affected
249 syringes
Distribution
Nationwide in the US
Location
Melbourne, FL

Frequently Asked Questions

What product was recalled?
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019. Recalled by Pacifico National, Inc. dba AmEx Pharmacy. Units affected: 249 syringes.
Why was this product recalled?
Defective Delivery System: difficult to express
Which agency issued this recall?
This recall was issued by the FDA Drug on May 8, 2019. Severity: Moderate. Recall number: D-1271-2019.